SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Mick Mørmøny
POKERSAM
tntpal
To: POKERSAM who wrote (1317737)9/4/2021 3:53:29 PM
From: Winfastorlose3 Recommendations  Read Replies (1) of 1571198
 
Yes indeed. For example. According to the greedy sickos in our government and at Big Pharma, cheap Ivermectin bad. But the expensive clone of Ivermectin? EXCELLENT!

The latest scam: Pfizer developing ivermectin clone that will cost 100x more…

“Success against #COVID19 will likely require both vaccines & treatments,” Pfizer CEO Albert Bourla said on Wednesday. “We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.”

Pfizer also put out a press release the same week that proclaimed, “If successful, [the drug] has the potential to address a significant unmet medical need, providing patients with a novel oral therapy that could be prescribed at the first sign of infection, without requiring hospitalization.”
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext